by Josh Forsythe, on March 24, 2015
ST LOUIS, MO – PierianDx announced today that its genomic testing platform will soon produce a PDx Score giving clinicians prioritized, actionable and deeply informed data for a quicker diagnosis. PierianDx also announced the addition of clinical trials, FDA drug labels, and treatment guidelines from the National Comprehensive Cancer Network and the American Society of Clinical Oncology to its industry-leading knowledgebase.
Read Story
6 City Place
Creve Coeur, MO 63141
314-628-0035